Adolescent DevelopmentGENESISNCT07485673
GENESIS Project: Generating Evidence on the Needs of Ecuadorian Adolescents
An observational study of Adolescent Development and Mental Health Issue, run by Universidad de Especialidades Espiritu Santo at 1 site in Ecuador.
Trial summary
Background: Adolescence is a period of intensified emotional responses and occurs when mental health disorders commonly develop since adolescents are learning how to deal with powerful emotions. Globally, 15% of adolescents experience a mental disorder like depression or anxiety. Read more about this study
- Who is it for?
- Ages 14 to 19 yearsHealthy volunteers can take part
- Conditions the study is for
- Adolescent Development, Mental Health Issue, Lifestyle Factors
- What is being tested?
- Observational
- How many people
- 1,450 participants
- Where
- 1 siteEcuador
- Study dates
- 4 Sep 2025to Aug 2030
- How long will I take part?
- 5 Years
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 19 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: School-aged adolescents between 14 and 19 years of age in Quito
Who may be able to join
- be between 14 and 19 years old
Who cannot join
- have any disorder or treatment that contraindicated physical activity or that demanded special assistance
- be under some pharmacological treatment;
- not be authorized by parents, caregivers, or legal guardians to participate in the research project
- do not agree to take part in the research project
- for volunteering retirement.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Ecuador1 site, 1 recruiting
- Recruiting
UEF "Quito"
Quito, Pichincha
Doris Quiroz, MPH
About this study
Official title: Generating Evidence on the Needs of Ecuadorian Adolescents
Background: Adolescence is a period of intensified emotional responses and occurs when mental health disorders commonly develop since adolescents are learning how to deal with powerful emotions. Globally, 15% of adolescents experience a mental disorder like depression or anxiety. However, adolescent mental health goes beyond mental disorders. It is state of mental well-being that allows individuals to deal with stressors, recognize their abilities, develop their activities well, and participate in society, providing a holistic approach that highlights the interplay between psychological well-being and other aspects of life. Given this perspective, a Lifestyle Medicine (LM) approach based on a multi-component framework is needed for assessing adolescents' mental health. This study aims to evaluate adolescents' (aged 14-19) mental health, identify and mitigate the risks of developing any mental health disorder as well as formulate comprehensive interventions to promote and increase their emotional wellbeing. Methods: Cross-sectional and longitudinal studies will be performed. Adolescents from Quito, Ecuador will be recruited using a simple random sampling technique. The minimum sample size is 385; however, to increase the precision of the estimates, a target sample of approximately 1000 participants will be established. Main outcome measure will be mental health using social determinants of health and lifestyle medicine factors. Conclusion: This research project will evaluate adolescents' mental health through a holistic and multiapproach evaluation and interrelate social determinants of health and lifestyle medicine variables to propose and design multidisciplinary strategies and interventions to prevent and mitigate mental health outcomes in adolescents. Additionally, the results will be useful in informing public health authorities to evaluate or modify current policies
- Being tested
- Observational
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ObservationalOther
The study will include the administration of self-reported validated scales to assess adolescents's mental health outcomes and the six pillars of Lifestyle Medicine. In addition, anthropometric measurements and vital signs will be obtained, and participants' physical activity levels will be evaluated. Biological samples, including blood and hair, will also be collected for further analysis.
| Study group | Role | What they receive |
|---|---|---|
| Wave 1 | Administration of validated scales to assess mental health outcomes and the six pillars of Lifestyle Medicine.
Anthropometric measurements. Physical activity evaluation. Blood and hair sample collection. Receives: Other: Observational |
What is being measured
The primary outcome is the main question the study is designed to answer.
Comprehensive evaluation of the Ecuadorian adolescent's mental health
Adherence to the six pillars of lifestyle medicine and their relationship with adolescent's mental health
Measured: 2025
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Mar 2026
- Study start4 Sep 2025
- Primary completionAug 2030 (estimated)
- Study completionAug 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Adolescent DevelopmentStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 1,450 participants (estimated)
- Target duration
- 5 Years
Sponsor and investigators
- Lead sponsor
- Universidad de Especialidades Espiritu Santo
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, José Francisco López Gil, Universidad de Especialidades Espiritu Santo
- Investigators
- José Francisco López-Gil, PhD., Principal investigator, Universidad de Especialidades Espiritu Santo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07485673
- Sponsor's protocol ID
- C-UEES-25-18.1
- Acronym
- GENESIS
- Status last verified
- Mar 2026
- First submitted
- 16 Mar 2026
- Last updated
- 20 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No